# Lapacho Bark

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lapacho-bark
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-15
**Evidence Score:** 6 / 10
**Category:** Bark
**Also Known As:** Handroanthus impetiginosus, Tabebuia impetiginosa, Tabebuia avellanedae, Pau d'Arco, Ipe Roxo, Purple Lapacho

## Overview

Lapacho bark (Tabebuia impetiginosa) contains the naphthoquinone compounds lapachol and β-lapachone, which inhibit topoisomerase I activity, suppress COX-2-mediated [inflammation](/ingredients/condition/inflammation), and demonstrate broad-spectrum antimicrobial, wound-healing, and [immunomodulatory](/ingredients/condition/immune-support) effects. A 2013 study (PMID 23010281) showed β-lapachone significantly ameliorated autoimmune encephalomyelitis in vivo, while a 2024 single-cell transcriptomics study (PMID 38701542) revealed its derivative lapagyl mitigates UV-induced inflammation via Foxp3+ Treg modulation and CCL pathway suppression.

## Health Benefits

- **Supports robust immune**: defense by stimulating immune cell activity.
- **Exhibits potent antifungal**: and antimicrobial activity against various pathogens.
- **Reduces systemic inflammation**: by modulating [inflammatory pathway](/ingredients/condition/inflammation)s.
- **Aids in body**: detoxification by supporting [liver function](/ingredients/condition/detox) and toxin elimination.
- **May assist in**: managing infections and autoimmune conditions through [immunomodulatory](/ingredients/condition/immune-support) effects.

## Mechanism of Action

β-Lapachone and lapachol inhibit topoisomerase I enzyme activity, blocking DNA unwinding and replication in pathogenic and neoplastic cells, a mechanism confirmed in cytotoxicity studies (PMID 11474885). β-Lapachone suppresses the NF-κB signaling cascade, downregulating cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), thereby reducing prostaglandin E2 (PGE2) and [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including IL-1β, TNF-α, and IL-6. In autoimmune models, β-lapachone modulates adaptive [immunity](/ingredients/condition/immune-support) by influencing Foxp3+ regulatory T-cell populations and suppressing CCL chemokine-mediated immune cell recruitment (PMID 38701542). Additionally, β-lapachone activates NAD(P)H:quinone oxidoreductase 1 (NQO1)-dependent pathways, generating [reactive oxygen species](/ingredients/condition/antioxidant) selectively in NQO1-overexpressing cells, which underlies its selective cytotoxicity in tumor models (PMID 41299357).

## Clinical Summary

Current evidence for lapacho bark comes exclusively from preclinical laboratory and animal studies, with no completed human clinical trials confirming therapeutic effectiveness. In vitro studies demonstrate [antimicrobial](/ingredients/condition/immune-support) activity against Candida albicans and Cryptococcus neoformans with efficacy comparable to amphotericin B. Animal models show anticancer effects against breast, lung, prostate, and colon cancers, but clinical translation is limited by compound toxicity. The strength of evidence remains weak due to absence of controlled human trials.

## Nutritional Profile

- Minerals: Selenium.
- Phytochemicals & Bioactives: Naphthoquinones (Lapachol, Beta-lapachone), Flavonoids, Quinones.

## Dosage & Preparation

- Traditionally consumed as a decoction made from the inner bark.
- Widely used in Amazonian folk medicine for infections, Candida overgrowth, and [immune modulation](/ingredients/condition/immune-support).
- Recommended dosage: 1–2 cups of bark decoction daily, or 500–1000 mg standardized extract.
- Consult a healthcare professional for specific guidance, especially for prolonged use.

## Safety & Drug Interactions

High doses of lapachol have been associated with anticoagulant effects due to structural similarity to vitamin K, and concurrent use with warfarin or other blood-thinning medications should be avoided without medical supervision. Cytotoxicity studies (PMID 11474885) indicate dose-dependent toxicity of β-lapachone at high concentrations, underscoring the importance of controlled dosing. Lapacho bark naphthoquinones may interact with CYP450 enzymes, particularly CYP1A2 and CYP3A4, potentially altering the [metabolism](/ingredients/condition/weight-management) of co-administered pharmaceuticals. Pregnant or breastfeeding women, individuals with bleeding disorders, and those scheduled for surgery should avoid lapacho bark supplementation, and a healthcare provider should be consulted before combining it with immunosuppressant or anticoagulant drugs.

## Scientific Research

A comprehensive ethnopharmacological review by Gómez Castellanos et al. (2009) in the Journal of Ethnopharmacology (PMID 18992801) catalogued lapacho's global traditional uses and confirmed its naphthoquinone-driven antimicrobial and [anti-inflammatory](/ingredients/condition/inflammation) pharmacology. Xu et al. (2013) in the Journal of Neuroimmunology (PMID 23010281) demonstrated that β-lapachone ameliorated experimental autoimmune encephalomyelitis in a murine model, supporting its [immunomodulatory](/ingredients/condition/immune-support) potential. Kung et al. (2008) in the American Journal of Physiology–Cell Physiology (PMID 18650264) showed β-lapachone promoted wound healing both in vitro and in vivo by accelerating cell migration and [collagen synthesis](/ingredients/condition/skin-health). More recently, Xie et al. (2024) in Phytomedicine (PMID 38701542) used single-cell transcriptomics to reveal that the lapacho derivative lapagyl mitigates UV-induced inflammation and immunosuppression via Foxp3+ regulatory T cells and CCL chemokine pathway modulation.

## Historical & Cultural Context

For centuries, Lapacho Bark has been used by Indigenous tribes such as the Inca, Kallawaya, and Guarani as a sacred healing tree. Revered for its role in treating infections, reducing [inflammation](/ingredients/condition/inflammation), and spiritual cleansing, its bark tea was also used to strengthen vitality during disease recovery and purification rituals.

## Synergistic Combinations

Role: Bark botanical
Intention: Immune & [Inflammation](/ingredients/condition/inflammation) | Detox & Liver
Primary Pairings: Cat's Claw (Uncaria tomentosa); Chanca Piedra (Phyllanthus niruri); Turmeric (Curcuma longa); Burdock Root (Arctium lappa)

## Frequently Asked Questions

### What are the main active compounds in lapacho bark and how do they work?

The primary bioactive compounds are the naphthoquinones lapachol and β-lapachone. These molecules inhibit topoisomerase I to disrupt DNA replication in pathogens and tumor cells, while also blocking COX-2 and NF-κB inflammatory pathways. A 2009 ethnopharmacological review (PMID 18992801) confirmed these compounds as responsible for lapacho's broad antimicrobial and anti-inflammatory activity.

### Does lapacho tea have caffeine?

No, lapacho (Pau d'Arco) tea is naturally caffeine-free, making it suitable for consumption at any time of day without risk of sleep disruption. It is brewed from the inner bark of Tabebuia impetiginosa and provides its health benefits through naphthoquinones rather than stimulant alkaloids.

### Can lapacho bark help with wound healing?

Yes, research supports lapacho bark's wound-healing properties. Kung et al. (2008) demonstrated that β-lapachone promoted wound closure both in vitro and in vivo by enhancing cell migration and collagen synthesis (PMID 18650264). Fu et al. (2011) further showed that β-lapachone accelerated burn-wound skin recovery in a histological study (PMID 21630220).

### Is lapacho bark effective against autoimmune conditions?

Preclinical evidence is promising. Xu et al. (2013) published in the Journal of Neuroimmunology that β-lapachone significantly ameliorated experimental autoimmune encephalomyelitis in mice (PMID 23010281). Additionally, a 2024 single-cell transcriptomics study showed lapacho-derived lapagyl modulates Foxp3+ regulatory T cells involved in autoimmune suppression (PMID 38701542).

### What are the side effects of lapacho bark?

At therapeutic doses, lapacho bark is generally well-tolerated, but high doses may cause nausea, vomiting, and anticoagulant effects due to lapachol's vitamin K-antagonist properties. Cytotoxicity research (PMID 11474885) confirms dose-dependent cellular toxicity at elevated concentrations. Individuals on blood thinners, immunosuppressants, or those who are pregnant should consult a healthcare provider before use.

### How much lapacho bark should I take daily, and how should I prepare it?

Typical lapacho bark dosing ranges from 1–3 grams of dried bark per day, often prepared as a decoction by simmering in hot water for 5–15 minutes. The most common approach is to brew 1 teaspoon of dried bark per cup of water, consumed 1–3 times daily, though individual tolerance and health goals may warrant adjustment. Start with lower doses to assess tolerance, as lapacho is potent and effects can accumulate with regular use.

### Is lapacho bark safe to use during pregnancy or while breastfeeding?

Lapacho bark is not recommended during pregnancy or breastfeeding due to insufficient safety data and its potent immunomodulatory and antimicrobial properties, which could affect fetal development or pass into breast milk. Pregnant and nursing individuals should consult a healthcare provider before use, as some traditional uses suggest lapacho may influence hormonal balance. The risk-benefit profile is not well-established for these vulnerable populations.

### Does lapacho bark interact with common medications like antibiotics or immunosuppressants?

Lapacho bark's antimicrobial and immunomodulatory effects may interact with antibiotics and immunosuppressant medications, potentially reducing their effectiveness or causing conflicting immune responses. It may also interact with blood-thinning medications and antidiabetic drugs due to its bioactive compounds and systemic effects. Anyone taking prescription medications should consult a healthcare provider before adding lapacho bark to avoid adverse interactions.

## References

Gómez Castellanos JR et al. (2009). Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity? Journal of Ethnopharmacology. PMID: 18992801 — Xu J et al. (2013). β-Lapachone ameliorization of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. PMID: 23010281 — Müller K et al. (1999). Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth. Journal of Natural Products. PMID: 10479319 — Coelho LL et al. (2025). β-lapachone impairs viability, migration, and epithelial-mesenchymal transition in mammary tumor spheroids. BMC Cancer. PMID: 41299357 — Kung HN et al. (2008). In vitro and in vivo wound healing-promoting activities of beta-lapachone. American Journal of Physiology–Cell Physiology. PMID: 18650264 — Dubin M et al. (2001). Cytotoxicity of beta-lapachone, an naphthoquinone with possible therapeutic use. Medicina (Buenos Aires). PMID: 11474885 — Xie Y et al. (2024). Lapagyl mitigates UV-induced inflammation and immunosuppression via Foxp3+ Tregs and CCL pathway: A single-cell transcriptomics study. Phytomedicine. PMID: 38701542 — Fu SC et al. (2011). β-lapachone accelerates the recovery of burn-wound skin. Histology and Histopathology. PMID: 21630220

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*